Global Situation & Resulting Influences - Research Report on Oculus Innovative Sciences, Inc. and Allergan, Inc.

MACAU, Sep 23 (MARKET WIRE) --
Today, www.EquityMarketsInc.com announced its research report
highlighting Oculus Innovative Sciences, Inc. (NASDAQ: OCLS) and
Allergan, Inc. (NYSE: AGN). Full content and research is available at
www.EquityMarketsInc.com/research.php?id=OCLS+AGN.

Continued confidence in long-term U.S. debt is defying S&P's recent
downgrade. Treasury yields continue at their lowest levels since January
1, 2011 as the market moved to "safe investments," wary of the storm
clouds ahead. Winds can change however, as a last-minute move to save the
U.S. from a historic default on its debt obligations. Attentions are now
turned to the situation in Europe, with the health of the Euro in the
balance; bankers are looking to prevent defaults on Italian and Spanish
debt.

As a result of recent credit adjustments, opportunity is being marked for
investors to take advantage of equities with high-margin and specialty
products. Market-wise investors are carefully watching for value within
equities boasting established pipelines and excellent growth prospects.
As part of this process, the following companies have been introduced
with initial research reports available online.

Equity Markets has reviewed Oculus Innovative Sciences, Inc. for its
current position within the healthcare industry. Oculus Innovative
Sciences, Inc. develops, manufactures and markets a family of tissue care
products that cure infections, and through a separate mechanism of
action, enhance healing while reducing the need for antibiotics. The full
research report on Oculus Innovative Sciences, Inc. (NASDAQ: OCLS) is
available here: www.EquityMarketsInc.com/research.php?id=OCLS.

Equity Markets has reviewed Allergan, Inc. for its development within the
healthcare industry. Allergan, Inc. (Allergan) is a multi-specialty
health care company focused on developing and commercializing
pharmaceuticals, biologics, medical devices and over-the-counter
products. The full research report on Allergan, Inc. (NYSE: AGN) is
available here: www.EquityMarketsInc.com/research.php?id=AGN.

About Equity Markets
Our mission at Equity Markets is to be the best
source of content and research, while educating, enlightening and
informing investors. Equity Markets combines street smart analysts and
professional market researchers to provide investors with detailed
company profiles and market coverage.

Contact:

Samuel Littman
press@equitymarketsinc.com
www.EquityMarketsInc.com

Copyright 2011, Market Wire, All rights reserved.

-0-